z-logo
open-access-imgOpen Access
A Deep Learning Technique for Classification of Breast Cancer Disease
Author(s) -
Dr.Yelepi Usha Rani,
Lakshmi Sowmya Kotturi,
G Sudhakar
Publication year - 2021
Publication title -
international journal of engineering and advanced technology
Language(s) - English
Resource type - Journals
ISSN - 2249-8958
DOI - 10.35940/ijeat.a3119.1011121
Subject(s) - artificial intelligence , random forest , support vector machine , machine learning , computer science , breast cancer , decision tree , naive bayes classifier , cancer , resampling , metric (unit) , pattern recognition (psychology) , algorithm , medicine , operations management , economics
In recent years researchers are intensely using machine learning and employing AI techniques in the medical field particularly in the domain of cancer. Breast cancer is one such example and many studies have proposed CAD systems and algorithms to efficiently detect cancer cells and tumors. Breast cancer is one of the dreadful cancers accounting for a large portion of deaths caused due to cancer worldwide mostly affecting women, needs early detection for proper diagnosis, and subsequent decrease in death rate. Thus, for efficient classification, we implemented different ML techniques on Wisconsin dataset [1] namely SVM, KNN, Decision Tree, Random Forest, Naive Bayes using accuracy as a performance metric, and as per observance, SVM has shown better results when compared to other algorithms. Also, we worked on Breast Histopathology Images [2] scanned at 40x which had images of IDC which is one of the most common types of breast cancers. And to work with the image dataset along with EDA we used high-end techniques like a mobile net where smote a resampling was used to handle imbalanced class distribution, CNN, SVC, InceptionResNetV2 where frameworks like Tensor Flow, Keras were loaded for supporting the environment and smoothly implement the algorithms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here